Diagnostic Accuracy of Ultrasound for Adenomyosis-A Blinded, Retrospective, Single-Expert Validation Study of the 2022 MUSA Guidelines
article
OA: closed
CC0
AI-generated summary
This retrospective study validated the 2022 MUSA guidelines, finding that ultrasound demonstrated diagnostic accuracy for adenomyosis when interpreted by a single expert.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
STUDY OBJECTIVE: To examine the predictive value of the 2022 Morphological Uterus Sonographic Assessment ultrasound markers for the diagnosis of adenomyosis.
DESIGN: Retrospective cohort study.
SETTING: Large academic medical center.
PATIENTS: Patients who underwent a hysterectomy procedure in 2022 and had an ultrasound within the prior year at a specialized gynecologic ultrasound center.
INTERVENTIONS: Hysterectomy and preoperative transvaginal ultrasound.
MEASUREMENTS AND MAIN RESULTS: The images were reviewed by an obstetrician-gynecologist specialized in gynecologic ultrasound who was blinded to the pathology results. Presence or absence of each Morphological Uterus Sonographic Assessment marker was documented and compared to the pathology results. The sensitivity, specificity, and area under the curve (AUC) were calculated for each individual finding and for composite measures. Our sample included 26 hysterectomies. The histologic prevalence of adenomyosis was 46.2%. The composite direct markers had a sensitivity of 100% (95% CI: 100.0-100.0) and a specificity of 35.7% (95% CI: 10.6-60.8) with an AUC of 65.4 (95% CI: 47.1-83.7). The marker with the highest AUC was echogenic subendometrial lines and buds with a sensitivity of 83.3 (95% CI: 62.2-100.0), and a specificity of 64.3 (95% CI: 39.2-89.4), and AUC of 73.1 (95% CI: 56.0-90.1). The direct finding with the lowest sensitivity but highest specificity was myometrial cysts with a sensitivity of 25% (95% CI: 0.5-49.5) and a specificity of 85.7 (95% CI: 67.4-100.0) and AUC of 57.7 (95% CI: 38.7-76.7).
CONCLUSION: In this blinded validation study of recently published guidelines on the ultrasound findings indicative of adenomyosis, we found a high sensitivity for the composite direct findings and all findings. The finding with the highest AUC was subendometrial lines and buds. Although this is a small study, it is a promising look at the value of ultrasound markers in predicting adenomyosis.
My notes (saved in your browser only)
Condition tags
MeSH descriptors
Citation neighborhood
Papers in the corpus that this work cites (lower rings, blue) and that cite this one (upper rings, green). Dot size scales with the paper's in-corpus citation count — bigger dot = more influential within the endo/adeno field. Click a dot to open that paper. [ expand to 2 hops ] — adds papers reached through this work's immediate citers/citees. Heavier; up to 60 extra dots.
References (13)
- Adenomyosis: Mechanisms and Pathogenesis via openalex
- Classification and Reporting Systems for Adenomyosis via openalex
- Imaging for Adenomyosis: Making the Diagnosis by Sonography via openalex
- Pathogenesis of uterine adenomyosis: invagination or metaplasia? via openalex
- Pathophysiology of adenomyosis via openalex
- Role of transvaginal sonography and magnetic resonance imaging in the diagnosis of uterine adenomyosis via openalex
- Terms, definitions and measurements to describe sonographic features of myometrium and uterine masses: a consensus opinion from the Morphological Uterus Sonographic Assessment (MUSA) group via openalex
- Transvaginal sonography in the diagnosis of adenomyosis: which findings are most accurate? via openalex
- Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology via openalex
- W6783937282 via openalex
- W2916403055 via openalex
- W2983644103 via openalex
- W3204011092 via openalex
Cited by (2)
Source provenance
- europepmc
- last seen: 2026-07-31T06:09:14.520117+00:00
- openalex
- last seen: 2026-06-10T17:14:06.276822+00:00
- pubmed
- last seen: 2026-07-31T06:05:18.338648+00:00
- unpaywall
- last seen: 2026-06-02T02:00:03.124865+00:00
License: CC0
· commercial use OK